These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 34105477)
1. [Clinical Analysis of Patients with MGUS, Primary Light Chain Amyloidosis, Multiple Myeloma or Multiple Myeloma with Concurrent Amyloidosis]. Mao XH; Deng SH; Sui WW; Fu MW; Liu JH; Fan HS; Zou DH; Zhao YZ; Qiu LG; An G Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):812-818. PubMed ID: 34105477 [TBL] [Abstract][Full Text] [Related]
2. Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS. Kaufmann H; Ackermann J; Odelga V; Sagaster V; Nösslinger T; Pfeilstöcker M; Keck A; Ludwig H; Gisslinger H; Drach J Eur J Clin Invest; 2008 Jan; 38(1):53-60. PubMed ID: 18173551 [TBL] [Abstract][Full Text] [Related]
3. Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance. Kim SY; Im K; Park SN; Kim JA; Yoon SS; Lee DS Leuk Res; 2016 May; 44():45-52. PubMed ID: 27015231 [TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia. Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602 [TBL] [Abstract][Full Text] [Related]
5. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma. Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability. Bochtler T; Hegenbart U; Cremer FW; Heiss C; Benner A; Hose D; Moos M; Bila J; Bartram CR; Ho AD; Goldschmidt H; Jauch A; Schonland SO Blood; 2008 May; 111(9):4700-5. PubMed ID: 18305218 [TBL] [Abstract][Full Text] [Related]
7. Differences in the distribution of cytogenetic subtypes between multiple myeloma patients with and without a family history of monoclonal gammopathy and multiple myeloma. Greenberg AJ; Cousin M; Kumar S; Ketterling RP; Knudson RA; Larson D; Colby C; Scott C; Vachon CM; Vincent Rajkumar S Eur J Haematol; 2013 Sep; 91(3):193-195. PubMed ID: 23647020 [TBL] [Abstract][Full Text] [Related]
8. The Landscape of Cytogenetic Aberrations in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma. He H; Lu J; Qiang W; Liu J; Liang A; Du J J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836158 [TBL] [Abstract][Full Text] [Related]
9. Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis. Harrison CJ; Mazzullo H; Ross FM; Cheung KL; Gerrard G; Harewood L; Mehta A; Lachmann HJ; Hawkins PN; Orchard KH Br J Haematol; 2002 May; 117(2):427-35. PubMed ID: 11972529 [TBL] [Abstract][Full Text] [Related]
10. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma. Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229 [TBL] [Abstract][Full Text] [Related]
11. [Genetic abnormality in 101 cases of plasma cell dyscrasias by FISH technology and cytogenetic examination]. Cao P; Li G; Tan Q; Zhang Y; Zhang G; Li X; He Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jul; 41(7):668-75. PubMed ID: 27592569 [TBL] [Abstract][Full Text] [Related]
12. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ]. Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009 [TBL] [Abstract][Full Text] [Related]
13. Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis. Visram A; Vachon C; Baughn LB; Larson D; Smadbeck J; Dispenzieri A; Kapoor P; Lacy MQ; Gertz MA; Buadi FK; Hayman SR; Dingli D; Kourelis T; Gonsalves W; Warsame R; Muchtar E; Leung N; Kyle RA; Rajkumar SV; Kumar S Leukemia; 2022 Apr; 36(4):1058-1065. PubMed ID: 34764424 [TBL] [Abstract][Full Text] [Related]
14. Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy. Sallustio F; Curci C; Solimando AG; Leone P; Pontrelli P; Gesualdo L; Vacca A; Racanelli V; Gallone A Cancer Biol Ther; 2021 Jun; 22(5-6):404-412. PubMed ID: 34288806 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311 [TBL] [Abstract][Full Text] [Related]
16. [Application Value of CD138 MACS-FISH in the Genetic Diagnosis of Plasma Cell Dyscrasia]. Mei JG; Li HQ; Cao HQ; Shao JJ; Zhai YP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1437-1442. PubMed ID: 27784371 [TBL] [Abstract][Full Text] [Related]
17. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark. Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB; Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249 [TBL] [Abstract][Full Text] [Related]
18. Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma. Chang SH; Gumbel J; Luo S; Thomas TS; Sanfilippo KM; Luo J; Colditz GA; Carson KR Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2055-2061. PubMed ID: 31501149 [TBL] [Abstract][Full Text] [Related]
19. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q). Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545 [TBL] [Abstract][Full Text] [Related]
20. The impact of clone size on the prognostic value of chromosome aberrations by fluorescence in situ hybridization in multiple myeloma. An G; Li Z; Tai YT; Acharya C; Li Q; Qin X; Yi S; Xu Y; Feng X; Li C; Zhao J; Shi L; Zang M; Deng S; Sui W; Hao M; Zou D; Zhao Y; Qi J; Cheng T; Ru K; Wang J; Anderson KC; Qiu L Clin Cancer Res; 2015 May; 21(9):2148-56. PubMed ID: 25652456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]